Precision recruitment for high-risk participants in a COVID-19 cohort study

被引:0
|
作者
Mezlini, Aziz M. [1 ]
Caddigan, Eamon [1 ]
Shapiro, Allison [1 ]
Ramirez, Ernesto [1 ]
Kondow-McConaghy, Helena M. [2 ]
Yang, Justin [3 ]
DeMarco, Kerry [3 ]
Naraghi-Arani, Pejman [3 ]
Foschini, Luca [1 ]
机构
[1] Evidat Hlth Inc, 63 Bovet Rd 146, San Mateo, CA 94402 USA
[2] Oak Ridge Inst Sci & Educ, 1299 Bethel Valley Rd, Oak Ridge, TN 37830 USA
[3] US Dept Hlth & Human Serv, Biomed Adv Res & Dev Author, Off Assistant Secretary Preparedness & Response, 200 Independence Ave, Washington, DC 20201 USA
关键词
COVID-19; Clinical trials; Risk modeling;
D O I
10.1016/j.conctc.2023.101113
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Studies for developing diagnostics and treatments for infectious diseases usually require observing the onset of infection during the study period. However, when the infection base rate incidence is low, the cohort size required to measure an effect becomes large, and recruitment becomes costly and prolonged. We developed a model for reducing recruiting time and resources in a COVID-19 detection study by targeting recruitment to highrisk individuals. Methods: We conducted an observational longitudinal cohort study at individual sites throughout the U.S., enrolling adults who were members of an online health and research platform. Through direct and longitudinal connection with research participants, we applied machine learning techniques to compute individual risk scores from individually permissioned data about socioeconomic and behavioral data, in combination with predicted local prevalence data. The modeled risk scores were then used to target candidates for enrollment in a hypothetical COVID-19 detection study. The main outcome measure was the incidence rate of COVID-19 according to the risk model compared with incidence rates in actual vaccine trials. Results: When we used risk scores from 66,040 participants to recruit a balanced cohort of participants for a COVID-19 detection study, we obtained a 4- to 7-fold greater COVID-19 infection incidence rate compared with similar real-world study cohorts. Conclusion: This risk model offers the possibility of reducing costs, increasing the power of analyses, and shortening study periods by targeting for recruitment participants at higher risk.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Protecting High-Risk Cardiac Patients During the COVID-19 Outbreak
    Pisano, Antonio
    Landoni, Giovanni
    Zangrillo, Alberto
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 34 (06) : 1698 - 1698
  • [42] Reply to "Focusing COVID-19 vaccinations on elderly and high-risk people"
    Mueller, Olaf
    Lu, Guangyu
    Razum, Oliver
    Jahn, Albrecht
    [J]. LANCET REGIONAL HEALTH-EUROPE, 2021, 3
  • [43] Propagation dynamics of COVID-19 in high-risk population dynamic network
    Shi Y.-Y.
    Nian F.-Z.
    Liu J.-S.
    Cao J.
    [J]. Kongzhi Lilun Yu Yingyong/Control Theory and Applications, 2020, 37 (03): : 461 - 468
  • [44] Reperfusion treatment for high-risk pulmonary embolism associated with COVID-19
    Barco, Stefano
    Munger, Mario
    Sebastian, Tim
    Kucher, Nils
    [J]. VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2020, 49 (04) : 257 - 258
  • [45] Disparities in COVID-19 Vaccine Coverage in High-risk Adult Population
    Felzer, J. R.
    Montgomery, A.
    LeMahieu, A.
    Rutten, L. J. Finney
    Juhn, Y. J.
    Wi, C.
    Jacobson, R. M.
    Kennedy, C. C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [46] Identification of high-risk COVID-19 patients using machine learning
    Quiroz-Juarez, Mario A.
    Torres-Gomez, Armando
    Hoyo-Ulloa, Irma
    Leon-Montiel, Roberto de J.
    U'Ren, Alfred B.
    [J]. PLOS ONE, 2021, 16 (09):
  • [47] Myeloproliferative neoplasias and Covid-19: an association of very high-risk pathologies
    Herbreteau, Laura
    Ianotto, Jean-Christophe
    [J]. HEMATOLOGIE, 2021, 27 (02): : 50 - 51
  • [48] Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients
    Ashraf, Farah
    Mazloom, Anita
    Nimkar, Neil
    Patel, Nisha
    Kalsi, Amardeep
    Singh, Angelica
    Paul, Sonal
    Vishnuvardhan, Nivetha
    Ashfaq, Abeer
    Usta, Soeb
    Kodama, Rich
    Kumarasinghe, Chathula
    Gregos, Peter
    Weingarten, Jeremy
    Khan, Uqba
    Patel, Eshan
    [J]. BLOOD, 2020, 136
  • [49] Allergic reactions to COVID-19 vaccine in Croatian high-risk patients
    Markovic, Ivan
    Lazarevic, Vesna Vukicevic
    Bozan, Marina
    Artukovic, Marinko
    Markovic, Asja Stipic
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 22 - 22
  • [50] COVID-19 in a high-risk dual heart and kidney transplant recipient
    Hsu, Jeffrey J.
    Gaynor, Pryce
    Kamath, Megan
    Fan, Ashley
    Al-Saffar, Farah
    Cruz, Daniel
    Nsair, Ali
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (07) : 1911 - 1915